Northern Trust
HCWB icon

Northern Trust’s HCW Biologics HCWB Stock Holding History

Northern Trust’s Portfolio HCWB Stock Details HCWB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-43
Closed -$2.88K – 4443
2025
Q1 		$2.88K Hold
43
– – ﹤0.01% 4415
2024
Q4 		$4.55K Hold
43
– – ﹤0.01% 4439
2024
Q3 		$5.5K Hold
43
– – ﹤0.01% 4401
2024
Q2 		$6.6K Hold
43
– – ﹤0.01% 4397
2024
Q1 		$17.9K Hold
43
– – ﹤0.01% 4345
2023
Q4 		$12.5K Hold
43
– – ﹤0.01% 4406
2023
Q3 		$19.4K Hold
43
– – ﹤0.01% 4336
2023
Q2 		$22.1K Buy
+43
New +$17.1K ﹤0.01% 4390

Other funds holding HCWB

GSWM
Golden State Wealth Management Santa Ana, California $1.1B AUM 27.49% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Northern Trust's HCWB Position: Q2 2025 in Review

Northern Trust sold out of HCW Biologics (HCWB) in Q2 2025, closing a stake of 43 shares — an estimated $2.88K sold.

Northern Trust first reported a position in HCWB in Q2 2023 and held it in 8 quarters. The position peaked at $22.1K in Q2 2023. 8 funds tracked by Wall St. Rank hold HCWB as of Q2 2025.

  • Northern Trust reported no remaining HCW Biologics position as of Q2 2025 after selling out during the quarter.
  • Northern Trust sold 43 HCW Biologics shares in Q2 2025, an estimated $2.88K.
  • Northern Trust first reported a position in HCW Biologics in Q2 2023 and held it in 8 quarters.
  • Northern Trust's HCW Biologics position peaked at $22.1K in Q2 2023.
  • 8 funds tracked by Wall St. Rank held HCW Biologics as of Q2 2025.

Based on Northern Trust's 13F filing for Q2 2025, filed 13 Aug 2025.